Looking for a stock that might be in a good position to beat earnings at its next report? Consider NuVasive, Inc. , a firm in the Medical Products industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, NUVA has beaten estimates by at least 15% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, NUVA expected to post earnings of 30 cents per share, while it actually produced earnings of 35 cents per share, a beat of 16.7%. Meanwhile, for the most recent quarter, the company looked to deliver earnings of 27 cents per share, when it actually saw earnings of 32 cents per share instead, representing a 18.5% positive surprise.
NUVASIVE INC Price and EPS Surprise
Thanks in part to this history, recent estimates have been moving higher for NuVasive. In fact, the Earnings ESP for NUVA is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for NUVA, as the firm currently has a Zacks Earnings ESP of 2.78%, so another beat could be around the corner.
This is particularly true when you consider that NUVA has a great Zacks Rank #2 (Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that NUVA could see another beat at its next report, especially if recent trends are any guide.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Image: Bigstock
Why NuVasive (NUVA) Could Beat Earnings Estimates Again
Looking for a stock that might be in a good position to beat earnings at its next report? Consider NuVasive, Inc. , a firm in the Medical Products industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, NUVA has beaten estimates by at least 15% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, NUVA expected to post earnings of 30 cents per share, while it actually produced earnings of 35 cents per share, a beat of 16.7%. Meanwhile, for the most recent quarter, the company looked to deliver earnings of 27 cents per share, when it actually saw earnings of 32 cents per share instead, representing a 18.5% positive surprise.
NUVASIVE INC Price and EPS Surprise
NUVASIVE INC Price and EPS Surprise | NUVASIVE INC Quote
Thanks in part to this history, recent estimates have been moving higher for NuVasive. In fact, the Earnings ESP for NUVA is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for NUVA, as the firm currently has a Zacks Earnings ESP of 2.78%, so another beat could be around the corner.
This is particularly true when you consider that NUVA has a great Zacks Rank #2 (Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that NUVA could see another beat at its next report, especially if recent trends are any guide.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>